Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Clinical value of cholinesterase in the prediction of biochemical recurrence after radical prostatectomy - D'Andrea_2018_Urol.Oncol_36_528 e7 |
| Author(s) : D'Andrea D , Soria F , Abufaraj M , Gust K , Foerster B , Vartolomei MD , Kimura S , Mari A , Briganti A , Remzi M , Seitz CK , Mathieu R , Karakiewicz PI , Shariat SF |
| Ref : Urol Oncol , 36 :528 e7 , 2018 |
| Abstract : D'Andrea_2018_Urol.Oncol_36_528 e7 |
| ESTHER : D'Andrea_2018_Urol.Oncol_36_528 e7 |
| PubMedSearch : D'Andrea_2018_Urol.Oncol_36_528 e7 |
| PubMedID: 30446461 |
| Title : The dipeptidyl peptidase IV inhibitor vildagliptin suppresses endogenous glucose production and enhances islet function after single-dose administration in type 2 diabetic patients - Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| Author(s) : Balas B , Baig MR , Watson C , Dunning BE , Ligueros-Saylan M , Wang Y , He YL , Darland C , Holst JJ , Deacon CF , Cusi K , Mari A , Foley JE , DeFronzo RA |
| Ref : J Clinical Endocrinology Metab , 92 :1249 , 2007 |
| Abstract : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| ESTHER : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| PubMedSearch : Balas_2007_J.Clin.Endocrinol.Metab_92_1249 |
| PubMedID: 17244786 |
| Title : Vildagliptin, a dipeptidyl peptidase-IV inhibitor, improves model-assessed beta-cell function in patients with type 2 diabetes - Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| Author(s) : Mari A , Sallas WM , He YL , Watson C , Ligueros-Saylan M , Dunning BE , Deacon CF , Holst JJ , Foley JE |
| Ref : J Clinical Endocrinology Metab , 90 :4888 , 2005 |
| Abstract : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| ESTHER : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| PubMedSearch : Mari_2005_J.Clin.Endocrinol.Metab_90_4888 |
| PubMedID: 15886245 |